NCT04355286View on ClinicalTrials.gov

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

November 6, 2020

Study Completion Date

November 17, 2020

Conditions
Absorption; ChemicalsSunscreening Agents
Interventions
DRUG

Bemotrizinol

Market-image topical sunscreen formulation containing BEMT (6%)

Trial Locations (1)

53095

Spaulding Clinical Research LLC, West Bend

All Listed Sponsors
collaborator

Spaulding Clinical Research LLC

OTHER

lead

DSM Nutritional Products, Inc.

INDUSTRY

NCT04355286 - Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study | Biotech Hunter | Biotech Hunter